ArticleThe oncologist2020

PD-L1 Expression on Circulating Tumor Cells May Be Predictive of Response to Pembrolizumab in Advanced Melanoma: Results from a Pilot Study.

Muhammad A Khattak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.